From: Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Classification | Source of dsDNA | Possible mechanisms | References | |
---|---|---|---|---|
Self-DNA | Micronuclei | Â | Rupture of the micronuclei membrane leads to exposure of chromatin DNA that is recognized by cGAS, which activates the cGAS-STING pathway. | [12] |
Mitochondrion | Â | Mitochondrial stress induces mtDNA leakage into the cytosol, thus activating the STING pathway and inducing production of cytokines. | [13] | |
Nuclear RNA | Â | Facilitated by endogenous retroelements, nuclear RNA can be reversely transcribed into DNA that activates cGAS-STING signaling. | [10] | |
Pathogen-derived DNA | DNA virus | HSV1, HSV2, KSHV, adenovirus, vaccinia virus, cytomegalovirus, papillomavirus, murine gamma-herpesvirus 68 | DNA viruses invade host cells and release pathogen-derived DNA to induce STING activation. | |
Retrovirus | HIV, SIV, murine leukemia virus | DNA intermediates generated from reverse transcription may be recognized by cGAS to stimulate downstream STING signaling. | [11] | |
RNA virus | West Nile virus, dengue virus, VSV, SARS-COV-2 | Infection with RNA viruses might cause cellular damage and cell death, which results in the release of cellular DNA and further activation of the cGAS-STING axis; SARS-CoV-2 binding to ACE2 can lead to excessive angiotensin II signaling that activates the STING pathway in mice. | ||
Bacteria | Listeria monocytogenes, Mycobacterium tuberculosis, Listeria, Shigella, Francisella, Chlamydia and Neisseria | Bacteria produce CDNs, such as cyclic di-GMP and cyclic di-AMP, which can directly bind to and activate STING. |